DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/tp6gzs/global_addiction) has announced the addition of the "Global Addiction Disorders Epidemiology and Patient Flow Analysis - 2012" report to their offering.
Fore Pharma announced the results of its Addiction Disorders patient population study in a new report Global Addiction Disorders Epidemiology and Patient Flow Analysis - 2012'. The report provides insights into Addiction Disorders epidemiology, Addiction Disorders diagnosed patients, and Addiction Disorders treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Addiction Disorders derived from epidemiological analysis, percentage of patients diagnosed with Addiction Disorders, and percentage of patients treated with Addiction Disorders therapy.
The study helps executives estimate Addiction Disorders market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The report provides estimates and forecasts of Addiction Disorders prevalence, Addiction Disorders diagnosis rate, and Addiction Disorders treatment rate for the period 2012-2019. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.
Key Topics Covered:
1. Addiction Disorders: Disease Definition
2. Global Addiction Disorders Patient Flow
2A. Global Addiction Disorders Prevalence
2B. Global Addiction Disorders Diagnosed Patients
2C. Global Addiction Disorders Treated Patients
3. Addiction Disorders Patient Flow in the US
3A. Addiction Disorders Prevalence in the US
3B. Addiction Disorders Diagnosed Patients in the US
3C. Addiction Disorders Treated Patients in the US
4. Addiction Disorders Patient Flow in Europe
4A. Addiction Disorders Prevalence in Europe
4B. Addiction Disorders Diagnosed Patients in Europe
4C. Addiction Disorders Treated Patients in Europe
5. Addiction Disorders Patient Flow in Germany
5A. Addiction Disorders Prevalence in Germany
5B. Addiction Disorders Diagnosed Patients in Germany
5C. Addiction Disorders Treated Patients in Germany
6. Addiction Disorders Patient Flow in France
6A. Addiction Disorders Prevalence in France
6B. Addiction Disorders Diagnosed Patients in France
6C. Addiction Disorders Treated Patients in France
7. Addiction Disorders Patient Flow in Spain
7A. Addiction Disorders Prevalence in Spain
7B. Addiction Disorders Diagnosed Patients in Spain
7C. Addiction Disorders Treated Patients in Spain
8. Addiction Disorders Patient Flow in Italy
8A. Addiction Disorders Prevalence in Italy
8B. Addiction Disorders Diagnosed Patients in Italy
8C. Addiction Disorders Treated Patients in Italy
9. Addiction Disorders Patient Flow in UK
9A. Addiction Disorders Prevalence in UK
9B. Addiction Disorders Diagnosed Patients in UK
9C. Addiction Disorders Treated Patients in UK
10. Addiction Disorders Patient Flow in Japan
10A. Addiction Disorders Prevalence in Japan
10B. Addiction Disorders Diagnosed Patients in Japan
10C. Addiction Disorders Treated Patients in Japan
11. Appendix
12. Research Methodology
12A. Sources
For more information visit http://www.researchandmarkets.com/research/tp6gzs/global_addiction